Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Analytik Jena Acquires California-Based UVP

By BiotechDaily International staff writers
Posted on 30 Apr 2013
Analytik Jena, AG (Jena, Germany) recently acquired all of the outstanding shares of UVP, LLC (Upland, CA, USA), including its subsidiary, Ultra-Violet Products, Ltd. (Cambridge UK).

UVP is a leading manufacturer of bioimaging systems for applications in proteomics, genomics, animal and plant sciences. The company also develops ultraviolet (UV) products, light sources, and laboratory equipment such as hybridization ovens, transilluminators, crosslinkers, and polymerase chain reaction (PCR) hoods.

The acquisition of UVP allows Analytik Jena to strengthen its presence in the US market and expand its product range. “With the acquisition of UVP, we are significantly expanding our business activities in the Life Science unit and are laying an excellent basis for developing our successful business model in the US and neighboring regions. Here, we are combining efficient sales structures, a well-coordinated product portfolio, and broad technological expertise in the respective core segments. Further extensive synergies are to arise, especially in sales in Europe and Asia. With UVP, Analytik Jena also gains a production plant in the US dollar currency area,” remarked Klaus Berka, CEO of Analytik Jena, AG.

Analytik Jena is a provider of analytic technology, life-science systems for bioanalytic applications, and high-end optical consumer products. With UVP’s incorporation into Analytik Jena’s life-science business unit, many synergies are expected.

According to Leighton Smith, UVP’s president and CEO, “UVP has an opportunity to contribute significantly to the growth and profitability of Analytik Jena’s Life Science business unit. Our combined manufacturing expertise, portfolio of products and distribution channels open up new market opportunities, and begins an exciting new chapter in UVP’s history of providing innovative products and solutions to our customers.”

Related Links:

Analytik Jena
UVP



RANDOX LABORATORIES
SLAS - Society for Laboratory Automation and Screening
BIOSIGMA S.R.L.
comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A 3-dimensional picture reveals how the antibodies in the experimental drug Zmapp bind to Ebola virus (Photo courtesy of the Scripps Research Institute).

Electron Microscope Imaging Shows How Experimental Anti-Ebola Drug Works

Electron microscope imaging has revealed how the experimental drug ZMapp binds to the Ebolavirus and provides insights into how the drug prevents growth of the pathogen. ZMapp, which was developed by... Read more

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel

e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit

A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage. Offering the potential to test... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.